Evidence map›Paper›PMID 23559332›Full record

Trial reportEuropean journal of pediatrics2013

Comparison between daily supplementation doses of 200 versus 400 IU of vitamin D in infants.

Erman Atas, Ferhan Karademır, Atilla Ersen, Cihan Meral, Secil Aydınoz, Selami Suleymanoglu, Mustafa Gultepe, İsmail Gocmen

Abstract readComparative StudyRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in European journal of pediatrics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Vitamin D prophylaxis in infancy.BMC pediatrics · 2021
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Shelf life after opening of prescription medicines and supplements with vitamin DEuropean journal of hospital pharmacy : science and practice · 2017
    Article
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Erman AtasDepartment of Pediatric Oncology, Gulhane Military Medical Academy, 06018 Etlik, Ankara, Turkey. eatasdr@gmail.com
Ferhan Karademır
Atilla Ersen
Cihan Meral
Secil Aydınoz
Selami Suleymanoglu
Mustafa Gultepe
İsmail Gocmen

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The daily supplementation of vitamin D is mandatory for infants. However, there are still conflicting opinions about the exact daily dose. Thus, we aimed to evaluate a daily supplementation dose of 200 IU is sufficient and compared the supplementation doses of 200 and 400 IU per day. One hundred and sixty-nine infants were randomly assigned to two groups (group 1, 200 IU/day; group 2, 400 IU/day) and there were 75 infants in group 1 and 64 were in group 2 with a total number of 139. The median levels of 25-hydroxyvitamin D3 were significantly increased in group 2 at the age of 4 months (group 1, 39.60 mcg/L; group 2, 56.55 mcg/L; p < 0.0001). We clearly demonstrated that at the age of 4 months, none of the infants on the group 2 had a serum level of 25-hydroxyvitamin D3 less than 30 mcg/L. However, 21.3% of the infants in group 1 had a level below 30 mcg/L. Thus, in order to avoid vitamin D deficiency and rickets, we recommend supplementation dose of vitamin D at 400 IU/day as a safe and effective dose.

Indexed as

Dietary SupplementsCalcifediolChromatography, High Pressure LiquidFemaleHumansInfantInfant, NewbornMaleReference ValuesRicketsVitamin D DeficiencyCalcifediol

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.